Advisor Group Holdings, Inc. Amicus Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$39.8 Billion
Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 4,077 shares of FOLD stock, worth $34,736. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,077

Previous 4,513 9.66%

Holding current value

$34,736

Previous $48,000 20.83%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$9.36 - $12.01 $4,080 - $5,236	-436 Reduced 9.66%	4,077 $38,000
Q3 2024 Nov 13, 2024	SELL	$9.55 - $12.09 $75,721 - $95,861	-7,929 Reduced 63.73%	4,513 $48,000
Q2 2024 Aug 13, 2024	SELL	$9.04 - $11.75 $35,364 - $45,966	-3,912 Reduced 23.92%	12,442 $123,000
Q1 2024 May 10, 2024	SELL	$11.43 - $14.24 $314,062 - $391,272	-27,477 Reduced 62.69%	16,354 $192,000
Q4 2023 Feb 12, 2024	BUY	$9.97 - $14.52 $242,280 - $352,850	24,301 Added 124.43%	43,831 $621,000
Q3 2023 Nov 13, 2023	BUY	$11.78 - $13.86 $49,075 - $57,740	4,166 Added 27.12%	19,530 $237,000
Q2 2023 Aug 10, 2023	SELL	$10.72 - $13.3 $2,154 - $2,673	-201 Reduced 1.29%	15,364 $192,000
Q1 2023 May 12, 2023	BUY	$10.91 - $13.54 $12,219 - $15,164	1,120 Added 7.75%	15,565 $172,000
Q4 2022 Feb 10, 2023	BUY	$9.89 - $12.7 $43,990 - $56,489	4,448 Added 44.49%	14,445 $176,000
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $3,721 - $4,832	379 Added 3.94%	9,997 $104,000
Q2 2022 Aug 10, 2022	BUY	$6.23 - $11.12 $1,613 - $2,880	259 Added 2.77%	9,618 $103,000
Q1 2022 May 04, 2022	BUY	$7.89 - $12.48 $16,253 - $25,708	2,060 Added 28.22%	9,359 $88,000
Q3 2021 Nov 05, 2021	SELL	$8.74 - $11.84 $13,564 - $18,375	-1,552 Reduced 17.53%	7,299 $70,000
Q2 2021 Aug 02, 2021	SELL	$8.71 - $10.72 $24,919 - $30,669	-2,861 Reduced 24.43%	8,851 $85,000
Q1 2021 May 13, 2021	BUY	$9.2 - $23.86 $79,340 - $205,768	8,624 Added 279.27%	11,712 $116,000
Q4 2020 Feb 10, 2021	BUY	$13.47 - $24.89 $148 - $273	11 Added 0.36%	3,088 $71,000
Q3 2020 Nov 12, 2020	BUY	$12.89 - $15.89 $20,482 - $25,249	1,589 Added 106.79%	3,077 $45,000
Q2 2020 Aug 14, 2020	SELL	$8.86 - $15.69 $3,047 - $5,397	-344 Reduced 18.78%	1,488 $24,000
Q1 2020 May 18, 2020	BUY	$6.63 - $11.16 $12,146 - $20,445	1,832 New	1,832 $16,000

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

283M

Call Options Held

467K

Put Options Held

515K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.39B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Amicus Therapeutics, Inc. Transaction History